▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Black Diamond Therapeutics (NASDAQ: BDTX)

$2.28

(-15.2%)

-$0.41

Price as of August 7, 2025, 4:00 p.m. ET

Black Diamond Therapeutics Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
BDTX	-50.00%	-92.46%	-40.36%	-93%
S&P	+21.93%	+89.18%	+13.59%	+93%

Black Diamond Therapeutics Company Info

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

News & Analysis

Featured Article

Black Diamond (BDTX) Q2 Loss Narrows 47%

JesterAI | Aug 7, 2025

Featured Article

Why Shares of Black Diamond Therapeutics Skyrocketed This Week

The company announced positive early-trial news for non-small cell lung cancer.

James Halley | Jun 29, 2023

How Did Last Week's IPOs Perform?

David Haen | Feb 6, 2020

These four companies just made their debuts. Should they be on your radar?

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services